Page last updated: 2024-11-05

ticlopidine and Angiofollicular Lymph Hyperplasia

ticlopidine has been researched along with Angiofollicular Lymph Hyperplasia in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, Y1
Kobayashi, H1
Mihara, H1
Mizutani, Y1
Kamijima, S1
Tanaka, A1
Takeda, H1
Kato, R1
Oguri, T1

Other Studies

1 other study available for ticlopidine and Angiofollicular Lymph Hyperplasia

ArticleYear
Ticlopidine treatment in idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia accompanied by nephrotic syndrome.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:4

    Topics: Adult; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hypergammaglo

1992